Our survey data and a review of the literature indicate that the attitudes and practices of clinicians in the areas of neonatal pain management have changed. Today, neonatal and pediatric populations are more readily treated with opioid agonists than in the past. The widespread use of opioids is still hampered by fears of tolerance and physical dependence. These fears are supported by reports of tolerance and dependence in neonates and infants continuously receiving morphine and fentanyl to provide analgesia during painful and stressful life-saving procedures. Much remains to be learned about the vulnerability of neonates and infants to become tolerant and dependent, and virtually nothing is known about the long-term consequences as these young patients become juveniles and adults.
One aim of this grant will explore the vulnerability of neonatal rats to become tolerant and dependent to opioids. Our preliminary studies reveal that neonatal rats continuously receiving fentanyl from osmotic minipumps become tolerant and dependent. However, reports conflict about whether high potency opioids, such as fentanyl, produce tolerance and dependence. Studies will be conducted to test the hypothesis that not all opioids produce the same degree of tolerance and dependence in neonatal rats. Tolerance and dependence will be characterized in neonatal rats chronically administered low (meperidine), intermediate (morphine) and high (fentanyl) potency agonists. Another aim of this grant will explore the long-term consequences of tolerance and dependence in neonatal rats. We will test the hypothesis that neonatal tolerance and dependence alters the subsequent antinociceptive sensitivity of rats to opioids as juveniles and adults. In utero opioid exposure was reported to alter opioid antinociception in adult rats. These animals appeared normal in every respect, except when tested with opioids. We will also test the hypothesis that neonates chronically treated with opioid will exhibit, on second exposure, a greater degree of tolerance and dependence as juvenile and adult rats than rats that were opioid-naive as neonates. No studies have yet examined the effects of a second opioid exposure later in life. Finally, we will test the hypothesis that neonatal tolerance and dependence increases the propensity of rats to self-administer opioids as juveniles and adults. Adult rats exposed in utero to opioid self- administer significantly more opioid than opioid-naive animals. It is hoped that information on opioid tolerance and dependence may yield better and safer treatment regimens for human neonates.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
3P50DA005274-11S2
Application #
6103985
Study Section
Project Start
1999-06-01
Project End
1999-07-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
11
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Bagdas, Deniz; Alkhlaif, Yasmin; Jackson, Asti et al. (2018) New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice. Neuropharmacology 138:72-79
Jackson, Kia J; Muldoon, Pretal P; Walters, Carrie et al. (2016) Neuronal calcium/calmodulin-dependent protein kinase II mediates nicotine reward in the conditioned place preference test in mice. Behav Pharmacol 27:50-6
Nass, Sara R; Long, Jonathan Z; Schlosburg, Joel E et al. (2015) Endocannabinoid Catabolic Enzymes Play Differential Roles in Thermal Homeostasis in Response to Environmental or Immune Challenge. J Neuroimmune Pharmacol 10:364-70
Muldoon, P P; Chen, J; Harenza, J L et al. (2015) Inhibition of monoacylglycerol lipase reduces nicotine withdrawal. Br J Pharmacol 172:869-82
Wolf, Carl E; Goldstein, Ashley; Poklis, Justin L et al. (2014) Evaluation of an enzyme immunoassay for the detection of methadone metabolite EDDP [2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine] in urine. J Clin Lab Anal 28:136-40
Poklis, Justin L; Devers, Kelly G; Arbefeville, Elise F et al. (2014) Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death. Forensic Sci Int 234:e14-20
Poklis, Justin L; Nanco, Carol R; Troendle, Michelle M et al. (2014) Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication. Drug Test Anal 6:764-9
Ignatowska-Jankowska, B M; Ghosh, S; Crowe, M S et al. (2014) In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects. Br J Pharmacol 171:1392-407
Bagdas, Deniz; Muldoon, Pretal P; Zhu, Andy Z X et al. (2014) Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice. Neuropharmacology 85:67-72
Burston, James J; Sagar, Devi Rani; Shao, Pin et al. (2013) Cannabinoid CB2 receptors regulate central sensitization and pain responses associated with osteoarthritis of the knee joint. PLoS One 8:e80440

Showing the most recent 10 out of 106 publications